drugset
drugset / Trial / NCT03498170

The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

NCT03498170 ↗

Phase 1 Completed 16 enrolled Mereo BioPharma
NaSingle-groupOpen-labelTreatment

Summary

An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.

Timeline

Start
2018-03-19
Primary completion
2018-05-03
Completion
2018-05-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acumapimod Small molecule 14 mg —
Subject Itraconazole Small molecule 200 mg —

Indications

No indication recorded.